For help on how to get the results you want, see our search tips.
110 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Referrals Remove Referrals filter
Referral type
Article 107 procedures (prior to July 2012) Remove Article 107 procedures (prior to July 2012) filter
Article 30 referrals Remove Article 30 referrals filter
Categories
Human Remove Human filter
-
List item
Referral: Sandimmun Neoral and associated names
ciclosporin, Article 30 referrals
Status: European Commission final decision, opinion/position date: 27/06/2013, EC decision date: 31/10/2013, Last updated: 20/12/2013 -
List item
Referral: Tazocin
piperacillin, tazobactam, associated names: Tazobac, Tazocel, Tazonam, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/10/2010, EC decision date: 21/02/2011, Last updated: 19/11/2013 -
List item
Referral: Octagam
human normal immunoglobulin, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 23/09/2010, EC decision date: 04/10/2010, Last updated: 18/11/2013 -
List item
Referral: Augmentin
amoxicillin, clavulanic acid, Article 30 referrals
Status: European Commission final decision, opinion/position date: 19/01/2009, EC decision date: 19/10/2009, Last updated: 18/11/2013 -
List item
Referral: Zinacef
cefuroxime sodium, associated names: Curocef, Curoxim, Curoxim Monovial, Curoxima, Curoxime, Zinnat, Zinocep, Zinocep Vena, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/05/2012, EC decision date: 10/09/2012, Last updated: 29/01/2013 -
List item
Referral: Zinnat
cefuroxime axetil, associated names: Cefuroxima Solasma, Cefuroxima Allen, Cefuroxima Duncan, Elobact, Nivador, Oraxim, Selan, Tilexim, Zinadol, Zipos, Zoref, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/05/2012, EC decision date: 23/08/2012, Last updated: 29/01/2013 -
List item
Referral: Flolan
epoprostenol, associated names: Epoprostenol, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/05/2012, EC decision date: 08/08/2012, Last updated: 14/09/2012 -
List item
Referral: Tavanic
levofloxacin, associated names: Levofloxacin, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/05/2012, EC decision date: 31/07/2012, Last updated: 12/09/2012 -
List item
Referral: Priorix
measles, mumps and rubella vaccine (live), Article 30 referrals
Status: European Commission final decision, opinion/position date: 15/03/2012, EC decision date: 25/05/2012, Last updated: 19/06/2012 -
List item
Referral: Buflomedil
buflomedil, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 17/11/2011, EC decision date: 13/02/2012, Last updated: 13/06/2012 -
List item
Referral: Femara
letrozole, associated names: Femar, Fémara, Loxifan, Article 30 referrals
Status: European Commission final decision, opinion/position date: 15/03/2012, EC decision date: 22/05/2012, Last updated: 12/06/2012 -
List item
Referral: Meprobamate
meprobamate, associated names: Equanil and other trade names, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 19/01/2012, EC decision date: 30/03/2012, Last updated: 08/06/2012 -
List item
Referral: Somatropin
somatropin, associated names: Genotropin, Humatrope, Maxomat, Norditropin, Saizen, Zomacton, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 15/12/2011, EC decision date: 27/02/2012, Last updated: 23/04/2012 -
List item
Referral: Lipitor
atorvastatin, associated names: Atorvastatin, Atorvastatina Nostrum, Atorvastatina Parke-Davis, Atorvastatina Pharmacia, Cardyl, Edovin, Liprimar, Orbeos, Prevencor, Sortis, Tahor, Texzor, Torvast, Totalip, Xarator, Zarator, Article 30 referrals
Status: European Commission final decision, opinion/position date: 23/09/2010, EC decision date: 13/12/2010, Last updated: 10/04/2012 -
List item
Referral: Norvasc
amlodipine, associated names: Amlodipine Pfizer, Amlodipino, Amlor, Istin, Monopina, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/07/2011, EC decision date: 07/10/2011, Last updated: 29/03/2012 -
List item
Referral: Tienam
imipenem, cilastatin, associated names: Conet, Imipem, Primaxin, Tenacid, Zienam, Article 30 referrals
Status: European Commission final decision, opinion/position date: 16/12/2010, EC decision date: 10/03/2011, Last updated: 20/02/2012 -
List item
Referral: Diflucan
fluconazole, associated names: Fluconazole, Fungustatin, Fungata, Triflucan, Article 30 referrals
Status: European Commission final decision, opinion/position date: 23/06/2011, EC decision date: 02/09/2011, Last updated: 02/02/2012 -
List item
Referral: Protium
pantoprazole, associated names: Anagastra, Apton, Controloc, Eupantol, Inipomp, Pantec, Pantecta, Pantipp, Panto-Byk-20 / 40 / IV, Pantoc, Pantoloc, PantoLomberg, Pantopan, Pantorc, Pantozol, Peptazol, Rifun, Somac, Ulcotenal, Zurcal, Zurcale, Zurcazol, Article 30 referrals
Status: European Commission final decision, opinion/position date: 17/12/2009, EC decision date: 15/04/2010, Last updated: 17/01/2012 -
List item
Referral: Bufexamac
bufexamac, associated names: Parfenac, Bufal, Calmaderm, Fansamac, Mastu S, Parfenoide, Proctosan, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 22/04/2010, EC decision date: 27/07/2010, Last updated: 10/11/2011 -
List item
Referral: Vascace Plus
cilazapril, hydrochlorothiazide, associated names: Co-Inhibace, Dynorm Plus, Inhibace Plus, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/10/2010, EC decision date: 21/01/2011, Last updated: 09/11/2011 -
List item
Referral: Ketoprofen topical
ketoprofen, associated names: Fastum, Ketum, Orudis, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 22/07/2010, EC decision date: 29/11/2010, Last updated: 28/10/2011 -
List item
Referral: Atacand Plus
candesartan, hydrochlorothiazide, associated names: Atacand Zid, Blopresid, Blopress Comp, Blopress Plus, CoKenzen, Hytacand, Parapres Plus, Ratacand Plus, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/06/2010, EC decision date: 16/09/2010, Last updated: 21/09/2011 -
List item
Referral: Losec
omeprazole, associated names: Antra, Logastric, Losec Forte, Mopral, Omeprazen, Omeprazole, AstraZeneca, Zoltum, Article 30 referrals
Status: European Commission final decision, opinion/position date: 20/01/2010, EC decision date: 10/06/2010, Last updated: 19/09/2011 -
List item
Referral: Lescol
fluvastatin, associated names: Canef, Cardiol, Cardiol XL, Cranoc, Digardil, Digaril Prolib, Fluvastatin Novartis, Fluvastatina, Fractal, Leposit Prolib, Lescol Depot, Lescol Exel, Lescol LP, Lescol MR, Lescol Prolib, Lescol XL, Lipaxan, Lipaxin, Liposit, Locol, Lymetel, Primesin, Vaditon, Vaditon Prolib, Article 30 referrals
Status: European Commission final decision, opinion/position date: 19/11/2009, EC decision date: 15/03/2010, Last updated: 13/09/2011 -
List item
Referral: Kytril
granisetron, associated names: Kevatril, Article 30 referrals
Status: European Commission final decision, opinion/position date: 19/05/2011, EC decision date: 20/07/2011, Last updated: 12/09/2011